Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues

Oncology Reports

Volumn 13, Issue 6, 2005, Pages 1043-1048

  Ogasawara, Sachiko ^a   Yano, Hirohisa ^a   Momosaki, Seiya ^a   Nishida, Naoyo ^a   Takemoto, Yumi ^a   Kojiro, Sakiko ^a   Kojiro, Masamichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer growth; Hepatocellular carcinoma; Infiltration; Matrix metalloproteinase; Tissue inhibitor of metalloproteinase

Indexed keywords

MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; BILE DUCT; COMPARATIVE STUDY; ENDOTHELIUM CELL; ENZYMOLOGY; GENETICS; HUMAN; KUPFFER CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; MACROPHAGE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BILE DUCTS; CARCINOMA, HEPATOCELLULAR; ENDOTHELIAL CELLS; HEPATOCYTES; HUMANS; KUPFFER CELLS; LIVER NEOPLASMS; MACROPHAGES; MATRIX METALLOPROTEINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 24744440612     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.6.1043     Document Type: Article

References (37)

1. Harada T, Arii S, Mise M, Imamura T, Higashitsuji H, Furutani M, Niwano M, Ishigami S, Fukumoto M, Seiki M, Sato H and Imamura M: Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas. J Hepatol 28: 231-239, 1998. (Pubitemid 28116431)
2. Arii S, Mise M, Harada T, Furutani M, Ishigami S, Niwano M, Mizumoto M, Fukumoto M and Imamura M: Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology 24: 316-322, 1996. (Pubitemid 26260026)
3. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL and Quigley JP: Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 274: 13066-13076, 1999.
4. Murakami T: Establishment and characterization of human hepatoma cell line (KIM-1). Acta Hepatol Jpn 25: 532-539, 1984.
5. Yano H, Kojiro M and Nakashima T: A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma. In Vitro Cell Dev Biol 22: 637-646, 1986. (Pubitemid 17022420)
6. Yano H, Maruiwa M, Murakami T, Fukuda K, Ito Y, Sugihara S and Kojiro M: A new human pleomorphic hepatocellular carcinoma cell line, KYN-2. Acta Pathol Jpn 38: 953-966, 1988.
7. Yano H, Iemura A, Fukuda K, Mizoguchi A, Haramaki M and Kojiro M: Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancercells. Hepatology 18: 320-327, 1993. (Pubitemid 23225103)
8. Haramaki M, Yano H, Iemura A, Momosaki S, Ogasawara S, Inoue M, Yamaguchi R, Kusaba A, Utsunomiya I and Kojiro M: A new human hepatocellular carcinoma cell line (HAK-2) forms various structures in collagen gel matrices. Hum Cell 10: 183-192, 1997.
9. Utsunomiya I, Iemura A, Yano H, Akiba J and Kojiro M: Establishment and characterization of a new human hepatocellular carcinoma cell line, HAK-3, and its response to growth factors. Int J Oncol 15: 669-675, 1999.
10. Ogasawara S, Yano H, Iemura A, Hisaka T and Kojiro M: Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines. Hepatology 24: 198-205, 1996. (Pubitemid 26249434)
11. Ueno H, Yamashita K, Azumano I, Inoue M and Okada Y: Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas. Int J Cancer 84: 470-477, 1999.
12. Lichtinghagen R, Huegel O, Seifert T, Haberkorn CI, Michels D, Flemming P, Bahr M and Boeker KH: Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Clin Chem 46: 183-192, 2000. (Pubitemid 30104241)
13. Yamanaka H, Makino K, Takizawa M, Nakamura H, Fujimoto N, Moriya H, Nemori R, Sato H, Seiki M and Okada Y: Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium. Lab Invest 80: 677-687, 2000. (Pubitemid 30340652)
14. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF and Libby P: Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. J Clin Invest 92: 2408-2418, 1993. (Pubitemid 23333549)
15. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994. (Pubitemid 24216953)
16. Sato H, Kinoshita T, Takino T, Nakayama K and Seiki M: Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393: 101-104, 1996. (Pubitemid 26298239)
17. Kaneyoshi T, Nakatsukasa H, Higashi T, Fujiwara K, Naito I, Nouso K, Kariyama K, Kobayashi Y, Uemura M, Nakamura SI, Iwasaki Y and Tsuji T: Actual invasive potential of human hepatocellular carcinoma revealed by in situ gelatin zymography. Clin Cancer Res 7: 4027-4032, 2001. (Pubitemid 34044623)
18. Nakamura H, Fujii Y, Ohuchi E, Yamamoto E and Okada Y: Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur J Biochem 253: 67-75, 1998. (Pubitemid 28182306)
19. Nomura H, Sato H, Seiki M, Mai M and Okada Y: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55: 3263-3266, 1995.
20. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980. (Pubitemid 10098769)
21. Hayasaka A, Suzuki N, Fujimoto N, Iwama S, Fukuyama E, Kanda Y and Saisho H: Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hepatology 24: 1058-1062, 1996. (Pubitemid 26365903)
22. Luca M, Huang S, Gershenwald JE, Singh RK, Reich R and Bar-Eli M: Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol 151: 1105-1113, 1997. (Pubitemid 27424320)
23. Okada Y, Tsuchiya H. Shimizu H, Tomita K, Nakanishi I, Sato H, Seiki M, Yamashita K and Hayakawa T: Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun 171: 610-617, 1990. (Pubitemid 20289428)
24. Lohi J, Lehti K, Westermarck J, Kahari VM and Keski-Oja J: Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 239: 239-247, 1996. (Pubitemid 26246526)
25. Sakamoto Y. Mafune K, Mori M, Shiraishi T, Imamura H, Takayama T and Makuuchi M: Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma. Int J Oncol 17: 237-243, 2000.
26. Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S and Mori M: Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 61: 2145-2153, 2001. (Pubitemid 32692040)
27. Tanaka S, Sugimachi K, Yamashita Y, Ohga T, Shirabe K, Shimada M and Wands JR: Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma. Hepatology 35: 861-867, 2002. (Pubitemid 34258380)
28. Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M and Okada Y: Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res 59: 467-473, 1999. (Pubitemid 29048885)
29. Iki K, Tsutsumi M, Kido A, Sakitani H, Takahama M, Yoshimoto M, Motoyama M, Tatsumi K, Tsunoda T and Konishi Y. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 20: 1323-1329, 1999. (Pubitemid 29341456)
30. Lafleur MA, Handsley MM, Knauper V, Murphy G and Edwards DR: Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J Cell Sci 115: 3427-3438, 1999. (Pubitemid 34994032)
31. Kang T, Yi J, Yang W, Wang X, Jiang A and Pei D: Functional characterization of MT3-MMP in transfected MDCK cells: progelatinase A activation and tubulogenesis in 3-D collagen lattice. FASEB J 14: 2559-2568, 2000.
32. Kang T, Nagase H and Pei D: Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network. Cancer Res 62: 675-681, 2002. (Pubitemid 34126940)
33. Yamamoto H, Itoh F, Adachi Y, Sakamoto H, Adachi M, Hinoda Y and Imai K: Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology 112: 1290-1296, 1997. (Pubitemid 27157543)
34. Honda M, Mori M, Ueo H, Sugimachi K and Akiyoshi T: Matrix metalloproteinase-7 expression in gastric carcinoma. Gut 39: 444-448, 1996. (Pubitemid 26338536)
35. Miwa S, Miyagawa S, Soeda J and Kawasaki S: Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma. Cancer 94: 428-434, 2002. (Pubitemid 34081373)
36. Adachi Y, Itoh F, Yamamoto H, Matsuno K, Arimura Y, Kusano M, Endoh T, Hinoda Y, Oohara M, Hosokawa M and Imai K: Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. Int J Oncol 13: 1031-1035, 1998. (Pubitemid 28506074)
37. Yamashita K, Azumano I, Mai M and Okada Y: Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int J Cancer 79: 187-194, 1998. (Pubitemid 28201692)